VanEck Biotech ETF
BBH
BBH
127 hedge funds and large institutions have $171M invested in VanEck Biotech ETF in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 33
68% less call options, than puts
Call options by funds: $627K | Put options by funds: $1.95M
Holders
127
Holding in Top 10
–
Calls
$627K
Puts
$1.95M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$3.57M | |
| 3 | +$2.61M | |
| 4 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
+$1.39M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$1.23M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$2.22M | |
| 3 | -$1.77M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.04M |
| 5 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$1M |